Please Wait a Moment
X

Articles

16Jul

CTS implements Ultrio Plus on the Panther

16 Jul, 2020 | Return|
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA testing and has been approved by the US FDA for WNV, ZIKA, and now Ultrio Elite testing.
 
The Procleix Panther instrument with its automated process will allow the CTS laboratories to operate with increased efficiencies with processing all three assays (WNV, ZIKA, Ultrio Elite) using a single pooled or individual donation sample. We expect less downtime and fewer NAT assay failures.
 
On Tuesday, July 7, 2020 CTS Phoenix and Tampa converted from Tigris Ultrio Plus to Panther Ultrio Elite. Our Charlotte, Dallas, and St. Louis labs implemented on July 13th.

Related

Join us for a Babesia webinar!

As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...

Read More >

Confirmatory Algorithm and Assay Changes Effective September 30, 2019

On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...

Read More >

FDA Updates Emergency Use Authorization for COVID-19 Convalescent Plasma

On December 28, 2021, the FDA updated the emergency use authorization  (EUA) for COVID-19 conva...

Read More >

World Patient Safety Day 2020

The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...

Read More >

Daylight Saving Time Begins March 10

Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...

Read More >
Long-time CTS Leader Josh Moon to Guide Operations as Chief Operating Officer

Long-time CTS Leader Josh Moon to Guide Operations as Chief Operating Officer

Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...

Read More >